2 results
8-K
EX-99.1
CPRX
Catalyst Pharmaceuticals Inc
13 Mar 24
Available in the U.S. by Prescription for Patients Aged Two Years and Older
5:01pm
enhancing the access and affordability of AGAMREE for every patient. We eagerly look forward to collaborating with healthcare providers to facilitate
8-K
EX-99.1
CPRX
Catalyst Pharmaceuticals Inc
27 Oct 23
Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals
4:30pm
enhancing affordability for all DMD patients. We look forward to successfully commercializing this product with a continued commitment to serving our
- Prev
- 1
- Next